Satu Tiainen1,2, Sanna Oikari3, Markku Tammi3, Kirsi Rilla3, Kirsi Hämäläinen4,5,6, Raija Tammi3, Veli-Matti Kosma4,5,6, Päivi Auvinen7,8. 1. Cancer Center, Kuopio University Hospital, P.O. Box 100, 70029, Kuopio, Finland. satu.tiainen@kuh.fi. 2. Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. satu.tiainen@kuh.fi. 3. Institute of Biomedicine, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. 4. Clinical Pathology and Forensic Medicine, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. 5. Biocenter Kuopio and Cancer Center of Eastern Finland, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland. 6. Clinical Pathology, Imaging Center, Kuopio University Hospital, P.O. Box 100, 70029, Kuopio, Finland. 7. Cancer Center, Kuopio University Hospital, P.O. Box 100, 70029, Kuopio, Finland. 8. Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, 70211, Kuopio, Finland.
Abstract
PURPOSE: Obesity and oversupply of glucose, e.g., due to nutritional factors may shape the tumor microenvironment favorable for tumor progression. O-GlcNAcylation, a reversible modification of intracellular proteins, influences on several cellular functions and is connected to many diseases including cancer. Glycosaminoglycan hyaluronan (HA) enhances tumor progression and in breast cancer HA accumulation associates strongly with poor outcome. In vitro studies have suggested that O-GlcNAcylation may enhance HA synthesis. The aim of this study was to investigate the correlations between O-GlcNAcylation, HA-related parameters, and disease outcome in a clinical breast cancer material consisting of 278 breast cancer cases. METHODS: In microscopic analyses, O-GlcNAc staining of the breast carcinoma cells was evaluated in several randomly picked high-power fields of each section. The extent of cytoplasmic O-GlcNAc staining was graded as either low or high according to the intensity of the staining and the percentage of stained cells. The extent of nuclear O-GlcNAc staining was categorized as either low or high according to the percentage of stained nuclei. RESULTS: A high extent of both cytoplasmic and nuclear O-GlcNAcylation correlated with an increased relapse rate, development of distant metastases, and poor outcome. A high extent of cytoplasmic O-GlcNAcylation correlated also with the accumulation of all hyaluronan synthase (HAS1-3) proteins and with a large amount of HA in the tumor stroma. In addition, a high extent of nuclear O-GlcNAcylation associated with obesity. CONCLUSIONS: The results suggest a mechanistic association between increased O-GlcNAcylation and HA synthesis, leading to a HA-rich microenvironment favorable for breast cancer progression.
PURPOSE:Obesity and oversupply of glucose, e.g., due to nutritional factors may shape the tumor microenvironment favorable for tumor progression. O-GlcNAcylation, a reversible modification of intracellular proteins, influences on several cellular functions and is connected to many diseases including cancer. Glycosaminoglycan hyaluronan (HA) enhances tumor progression and in breast cancerHA accumulation associates strongly with poor outcome. In vitro studies have suggested that O-GlcNAcylation may enhance HA synthesis. The aim of this study was to investigate the correlations between O-GlcNAcylation, HA-related parameters, and disease outcome in a clinical breast cancer material consisting of 278 breast cancer cases. METHODS: In microscopic analyses, O-GlcNAc staining of the breast carcinoma cells was evaluated in several randomly picked high-power fields of each section. The extent of cytoplasmic O-GlcNAc staining was graded as either low or high according to the intensity of the staining and the percentage of stained cells. The extent of nuclear O-GlcNAc staining was categorized as either low or high according to the percentage of stained nuclei. RESULTS: A high extent of both cytoplasmic and nuclear O-GlcNAcylation correlated with an increased relapse rate, development of distant metastases, and poor outcome. A high extent of cytoplasmic O-GlcNAcylation correlated also with the accumulation of all hyaluronan synthase (HAS1-3) proteins and with a large amount of HA in the tumor stroma. In addition, a high extent of nuclear O-GlcNAcylation associated with obesity. CONCLUSIONS: The results suggest a mechanistic association between increased O-GlcNAcylation and HA synthesis, leading to a HA-rich microenvironment favorable for breast cancer progression.
Entities:
Keywords:
Breast cancer; Hyaluronan; Hyaluronan synthase; O-GlcNAcylation
Authors: Katie J Sikes; Kristen Renner; Jun Li; K Jane Grande-Allen; Jennifer P Connell; Valbona Cali; Ronald J Midura; John D Sandy; Anna Plaas; Vincent M Wang Journal: J Orthop Res Date: 2018-07-13 Impact factor: 3.494
Authors: Bethany Mason; Susanne Flach; Felipe R Teixeira; Raquel Manzano Garcia; Oscar M Rueda; Jean E Abraham; Carlos Caldas; Paul A W Edwards; Heike Laman Journal: Cell Mol Life Sci Date: 2019-09-27 Impact factor: 9.261
Authors: Satu Tiainen; Amro Masarwah; Sanna Oikari; Kirsi Rilla; Kirsi Hämäläinen; Mazen Sudah; Anna Sutela; Ritva Vanninen; Juho Ikonen; Raija Tammi; Markku Tammi; Päivi Auvinen Journal: Breast Cancer Res Treat Date: 2019-11-12 Impact factor: 4.872
Authors: Sören Twarock; Christina Reichert; Katharina Bach; Oliver Reiners; Inga Kretschmer; Daniel J Gorski; Katharina Gorges; Maria Grandoch; Jens W Fischer Journal: Br J Pharmacol Date: 2019-12-09 Impact factor: 8.739
Authors: Victor Vitorino Lima; Vanessa Dela Justina; Rinaldo Rodrigues Dos Passos; Gustavo Tadeu Volpato; Paula Cristina S Souto; Sebastian San Martin; Fernanda Regina Giachini Journal: Front Physiol Date: 2018-09-12 Impact factor: 4.566